samedan logo
 
 
spacer
home > pmps > spring 2017 > new thinking
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

New Thinking

When it comes to complacency, Albert Einstein once remarked: “If you always do what you always did, you will always get what you always got.” This very principle applies in healthcare and for today’s seven billion global consumers, who are living longer, have better access to quality care and are demanding more choices, greater convenience and improved outcomes.

It is an evolving paradigm, and delivering sophisticated, high-value pharmaceuticals to emerging markets will require continuous new thinking. The same supply chain issues will continue to pose steady challenges – cost and compliance chief among them – but leveraging cold chain innovations will produce significant gains in years to come.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
Jan Denecker is responsible for executing UPS’s healthcare strategy in Europe. He joined the company in 2011 as Marketing Manager of Healthcare and led the launch of the department in Europe. In 2014, Jan was appointed Marketing Manager of Belgium and Luxembourg, responsible for business planning, revenue management, marketing and communications in both countries. He holds a Master’s degree in Law from the Université catholique de Louvain, Belgium, and a Master’s degree in Business Administration from the Vlerick School of Management, Belgium.
spacer
Jan Denecker
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

ICON Releases Environmental, Social and Governance Report

ICON announced today the release of its 2020 Environmental, Social and Governance (ESG) Report.
More info >>

White Papers

Life Cycle of an Analytical Method - a Case Study on the Monocyte Activation Test

Wickham Laboratories Limited

Pyrogens, a heterogeneous group of fever inducing contaminants, are comprised of microbial and non-microbial compounds; e.g. endotoxin (lipopolysaccharide, LPS) produced by Gram-negative bacteria, lipoteichoic acid (LTA) from Gram-positive bacteria, bacterial DNA (CpG-motive), endogenous pyrogens, virus and fungi particles or even fragments of packaging materials, plastic and dust. Contaminat ion wi th pyrogens in pharmaceutical products, biotherapeutics and on medical devices can lead to life threatening fever reactions. To ensure consumer safety, pyrogen testing is mandatory for parenteral products and medical devices.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement